Navigation Links
HemoShear Hires Industry Business Development Veteran Vincent Aurentz as Chief Business Officer

CHARLOTTESVILLE, Va., Aug. 6, 2013 /PRNewswire/ -- HemoShear, LLC, a leading developer of human-relevant systems for drug discovery and development, today announced that Vincent Aurentz has joined HemoShear as the Company's Chief Business Officer.  Mr. Aurentz is widely respected in the pharmaceutical industry and brings to HemoShear a very strong combination of executive management experience in pharmaceutical R&D, licensing and business development, as well as expertise in building strategic partnerships.  


Mr. Aurentz has worked for over 24 years in life sciences.  Most recently, he was Executive Vice President of the Customer Solutions Business at Quintiles where he created a new business model to engage their customers.  Previously, he spent almost nine years with Merck KGaA where he served as Executive Vice President, Portfolio Development, for Merck Serono and was a member of the Executive Management Board.   He was responsible for Licensing and Business Development, Global Product leadership for the R&D pipeline, and Portfolio Management.  Prior to his role at Merck Serono, he was Merck KGaA's Global Head of Licensing and Business Development.  Mr. Aurentz is formerly a co-founder and Managing Director of True North Partners, a venture capital and advisory business focused on the healthcare industry. He was also a partner for CSC Healthcare in New York and worked at Andersen Consulting (now known as Accenture).

"I am excited to join HemoShear's talented organization," said Mr. Aurentz.  "I was struck by the quality of the science that HemoShear has developed, its potential to improve the productivity of drug R&D, and their vision for broad partnerships with pharma.  In considering the opportunity to join HemoShear, I spoke with several executives in pharma who shared a consistent message regarding the value of HemoShear's science in understanding human biology and response to new drug candidates at a level that has not existed before."

"Vince is an outstanding addition to HemoShear's executive team.  As we grow, we want to recruit the best people in the industry to drive our business," said James Powers, HemoShear's CEO.  "Vince's expertise will help us unlock the immense value that our enabling science brings to our pharmaceutical partners' drug R&D programs."

About HemoShear, LLC

By applying physiologically accurate hemodynamics and biological transport to primary cell cultures, HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for applications throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. HemoShear's science leads to new medicines and improves human health.  

For information about HemoShear, please visit


Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. HemoShear to Present at Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Conference
2. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
3. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
4. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
5. Textile Company PurThread Technologies Opens Headquarters in Durham, North Carolina and Hires New Senior Staff
6. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
7. Ernst & Young LLP Bolsters Fraud Investigation & Dispute Services with New Hires and Promotions
8. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
9. Ganeden Biotech Hires New Marketing Manager
10. PathoGenetix Hires Food Safety Testing Expert John W. Czajka as Vice President of Business Development
11. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
Post Your Comments:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:7/20/2017)... 2017 Delta (NYSE: DAL ) customers now can ... at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan ... Delta,s biometric boarding pass experience that ... now integrated into the boarding process to allow eligible Delta SkyMiles Members ...
(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
Breaking Biology News(10 mins):